Sun Pharma shares jump 7% as India's largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.

Read Full Article

Tags: Israel

Sun Pharma shares jump 7% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

Related Posts

Wait, Could This Be a Climate Conference That Actually Works?

Suspected pirates steer cargo vessel towards Somalia: Security groups

Child advocates to rally for online harms bill covering AI chatbots, gaming

Negeri Sembilan in political turmoil as UMNO pulls support for chief minister over royal row

New Zealand and India sign landmark free trade agreement

Welcome Back!

Create New Account!

Retrieve your password

Sun Pharma shares jump 7% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

Related Posts

Wait, Could This Be a Climate Conference That Actually Works?

Suspected pirates steer cargo vessel towards Somalia: Security groups

Child advocates to rally for online harms bill covering AI chatbots, gaming

Negeri Sembilan in political turmoil as UMNO pulls support for chief minister over royal row

New Zealand and India sign landmark free trade agreement

Trending Topics

Welcome Back!

Create New Account!

Retrieve your password